Back

News

Investments

EpilepsyGTx raises $33m Series A to develop single dose gene therapy for focal refractory epilepsy

Learn More

News

Early trigger of diabetic eye disease identified

Learn More

Insights

Inside Albion Ventures’ decade-long partnership with UCL

Learn More

News

Breakthrough gene therapy transforms teenager’s life

Learn More

News

UCL Spinout Echopoint Medical Ltd Secures £4.2 Million in Series A Funding, Advancing FDA Approval Process for iKOr System

Learn More

Investments

Phasecraft raises $34M to bring quantum computing closer to real-world impact

Learn More

News

Tenpoint Therapeutics Announces Positive Topline Data from Phase 3 Pivotal Study

Learn More

News

Tenpoint Therapeutics & Visus Therapeutics, Inc. join forces building the next era of Best-and First-in-Class ophthalmic medicines

Learn More

Investments

Oriole Networks raises a further $22m led by Plural to reduce energy consumption of AI data centres

Learn More

News

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease

Learn More

News & Stories

Filter

News

Early trigger of diabetic eye disease identified

News

Breakthrough gene therapy transforms teenager’s life

News

Tenpoint Therapeutics Announces Positive Topline Data from Phase 3 Pivotal Study

News

Tenpoint Therapeutics & Visus Therapeutics, Inc. join forces building the next era of Best-and First-in-Class ophthalmic medicines

Investments

Oriole Networks raises a further $22m led by Plural to reduce energy consumption of AI data centres

News

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease

News

Cancer Research UK and NovalGen collaborate to advance T-cell engager into the clinic

News

AstronauTx appoints Jane Rhodes as Chief Executive Officer

News

New immunotherapy from UCL researchers to treat bone cancer shows promise

Let’s Talk

UCLTF offers investment throughout the spinout journey. We fund proof-of-concept and development projects, and support academics with company formation. We take applications year-round.

Learn More

Related Content

EpilepsyGTx raises $33m Series A to develop single dose gene therapy for focal refractory epilepsy

Early trigger of diabetic eye disease identified

Inside Albion Ventures’ decade-long partnership with UCL

Breakthrough gene therapy transforms teenager’s life

UCL Spinout Echopoint Medical Ltd Secures £4.2 Million in Series A Funding, Advancing FDA Approval Process for iKOr System

Phasecraft raises $34M to bring quantum computing closer to real-world impact

Tenpoint Therapeutics Announces Positive Topline Data from Phase 3 Pivotal Study

Tenpoint Therapeutics & Visus Therapeutics, Inc. join forces building the next era of Best-and First-in-Class ophthalmic medicines

Oriole Networks raises a further $22m led by Plural to reduce energy consumption of AI data centres

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease

News & Stories

Filter

Early trigger of diabetic eye disease identified

Breakthrough gene therapy transforms teenager’s life

Tenpoint Therapeutics Announces Positive Topline Data from Phase 3 Pivotal Study

Tenpoint Therapeutics & Visus Therapeutics, Inc. join forces building the next era of Best-and First-in-Class ophthalmic medicines

Oriole Networks raises a further $22m led by Plural to reduce energy consumption of AI data centres

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease

Cancer Research UK and NovalGen collaborate to advance T-cell engager into the clinic

AstronauTx appoints Jane Rhodes as Chief Executive Officer

New immunotherapy from UCL researchers to treat bone cancer shows promise

Let’s Talk